<--- Back to Details
First PageDocument Content
Health / Pharmaceuticals policy / RTT / Medicine / Healthcare reform in the United States / AARP / Medicare Part D / Medicare / Prostate cancer / Consumer Reports Best Buy Drugs / Medical prescription / Insomnia
Date: 2016-02-04 09:26:03
Health
Pharmaceuticals policy
RTT
Medicine
Healthcare reform in the United States
AARP
Medicare Part D
Medicare
Prostate cancer
Consumer Reports Best Buy Drugs
Medical prescription
Insomnia

HEALTHNET NEWS A newsletter for public librarians and others interested in consumer health information services Volume XX Number 3

Add to Reading List

Source URL: library.uchc.edu

Download Document from Source Website

File Size: 345,07 KB

Share Document on Facebook

Similar Documents

Announcement of Calendar Year (CYMedicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and Final Call Letter and Request for Information

Announcement of Calendar Year (CYMedicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and Final Call Letter and Request for Information

DocID: 1xTu9 - View Document

Medicare Part D stand-alone prescription drug plans for 2018 People who get their health benefits from a Medicare supplement policy or a non-managed care Medicare Advantage plan with no drug coverage may enroll in a stan

Medicare Part D stand-alone prescription drug plans for 2018 People who get their health benefits from a Medicare supplement policy or a non-managed care Medicare Advantage plan with no drug coverage may enroll in a stan

DocID: 1tPLN - View Document

Opioids in Medicare Part D: Concerns about Extreme Use and Questionable Prescribing (OEI; 07/17)

Opioids in Medicare Part D: Concerns about Extreme Use and Questionable Prescribing (OEI; 07/17)

DocID: 1ttzb - View Document

Mirror, Mirror on the Wall: Medicare Part D pays needlessly high brand-name drug prices compared with other OECD countries and with U.S. government programs By Marc-André Gagnon, PhD.

Mirror, Mirror on the Wall: Medicare Part D pays needlessly high brand-name drug prices compared with other OECD countries and with U.S. government programs By Marc-André Gagnon, PhD.

DocID: 1th0B - View Document

Coalition of 26 Groups to Congress: Oppose Medicare Part D Rebate Proposals June 21, 2016 Dear Senators and Representatives: In the final months of the Obama Administration, the White House and Congress will engage in an

Coalition of 26 Groups to Congress: Oppose Medicare Part D Rebate Proposals June 21, 2016 Dear Senators and Representatives: In the final months of the Obama Administration, the White House and Congress will engage in an

DocID: 1sahA - View Document